VYOME HOLDINGS, INC. Deferred Tax Assets, Tax Deferred Expense
VYOME HOLDINGS, INC. (HIND) had Deferred Tax Assets, Tax Deferred Expense of $793.00 thousand as of 2024-12-31, per its 10-K filed 2025-04-04.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpense · last filed 2025-04-04
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense $793.00K.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense $751.00K.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense $1.16M.
- 2021-12-31: Deferred Tax Assets, Tax Deferred Expense $1.68M.
| Period end | Deferred Tax Assets, Tax Deferred Expense |
|---|---|
| 2024-12-31 | $793.00K 10-K · filed 2025-04-04 |
| 2023-12-31 | $751.00K 10-K · filed 2025-04-04 |
| 2022-12-31 | $1.16M 10-K · filed 2024-04-01 |
| 2021-12-31 | $1.68M 10-K · filed 2023-04-17 |
| 2020-12-31 | $9.23M 10-K · filed 2022-04-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |